About Scolioscan
Scolioscan is a company based in Hong Kong (China) founded in 2012. Scolioscan has raised $5.52 million across 2 funding rounds from investors including Fosun Pharmaceutical, PolyU and AEF Greater Bay Area Fund. Scolioscan operates in a competitive market with competitors including EOS Iamging, OXOS Medical, Emerge Diagnostics, Aclarion and Knee Voice, among others.
- Headquarter Hong Kong, China
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$5.52 M (USD)
in 2 rounds
-
Latest Funding Round
$5.52 M (USD), Seed
Mar 26, 2024
-
Investors
Fosun Pharmaceutical
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Scolioscan
Scolioscan has successfully raised a total of $5.52M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $5.52 million completed in March 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Scolioscan
Scolioscan has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Fosun Pharmaceutical, PolyU and AEF Greater Bay Area Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Research, development, production, and sale of pharmaceuticals are provided.
|
Locked | Locked | Locked | |
|
Multiple courses and degrees are offered across diversified streams.
|
Locked | Locked | Locked |
Investor details for Scolioscan
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Scolioscan
Investment portfolio details for Scolioscan
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Scolioscan
Detailed financials for Scolioscan
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Scolioscan Comparisons
Peer comparison for Scolioscan
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Scolioscan
Scolioscan operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as EOS Iamging, OXOS Medical, Emerge Diagnostics, Aclarion and Knee Voice, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
2D/3D orthopedic imaging systems and software solutions are developed.
|
|
| Locked | Locked | Locked |
Orthopedic imaging devices and software are developed for surgical use.
|
|
| Locked | Locked | Locked |
Soft tissue injuries are diagnosed via a specialized electrodiagnostic device.
|
|
| Locked | Locked | Locked |
SaaS-based radiology image analysis tools are provided for medical providers.
|
|
| Locked | Locked | Locked |
Knee health is monitored via a wearable device during activities.
|
Detailed competitors of Scolioscan
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Scolioscan
Complete news archive for Scolioscan
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Scolioscan
Scolioscan was founded in 2012 and raised its 1st funding round 11 years after it was founded.
Scolioscan is headquartered in Hong Kong, China.
Margaret Han is the current CEO of Scolioscan.
Scolioscan is a funded company, having raised a total of $5.52M across 2 funding rounds to date.
Scolioscan was founded in 2012 in Hong Kong, China, within the medical imaging sector. A radiation-free 3D ultrasound system for scoliosis evaluation is provided through the portable Scolioscan Air device. Cloud-based ScolioNet software is utilized for spinal image analysis. Operations focus on non-invasive diagnostics, serving healthcare providers in the region and beyond.
Scolioscan's top competitors include EOS Iamging, OXOS Medical and Aclarion.
Scolioscan has 3 investors. Key investors include Fosun Pharmaceutical, PolyU, and AEF Greater Bay Area Fund.